News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,615 Results
Type
Article (44435)
Company Profile (413)
Press Release (706754)
Multimedia
Podcasts (151)
Webinars (24)
Section
Business (209622)
Career Advice (2052)
Deals (36279)
Drug Delivery (145)
Drug Development (84247)
Employer Resources (174)
FDA (16853)
Job Trends (15247)
News (354909)
Policy (33314)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2699)
Accelerated approval (58)
ADA (49)
Adcomms (33)
Allergies (199)
Alliances (51119)
ALS (236)
Alzheimer's disease (1911)
Antibody-drug conjugate (ADC) (557)
Approvals (17303)
Artificial intelligence (766)
ASCO (337)
Autoimmune disease (363)
Automation (63)
Bankruptcy (376)
Best Places to Work (11840)
BIO (74)
BIOSECURE Act (20)
Biosimilars (240)
Biotechnology (291)
Bladder cancer (209)
Brain cancer (79)
Breast cancer (824)
Cancer (6516)
Cardiovascular disease (530)
Career advice (1749)
Career pathing (47)
CAR-T (371)
CDC (60)
Celiac Disease (3)
Cell therapy (1016)
Cervical cancer (56)
Clinical research (73527)
Collaboration (2337)
Commercialization (1)
Company closure (5)
Compensation (1552)
Complete response letters (97)
COVID-19 (2819)
CRISPR (125)
C-suite (1304)
Cystic fibrosis (167)
Data (8821)
Decentralized trials (3)
Denatured (47)
Depression (188)
Dermatology (100)
Diabetes (679)
Diagnostics (7100)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (388)
Drug pricing (215)
Drug shortages (32)
Duchenne muscular dystrophy (327)
Earnings (93549)
Editorial (73)
Employer branding (21)
Employer resources (156)
Events (124494)
Executive appointments (1173)
FDA (20961)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1947)
Gene editing (268)
Generative AI (64)
Gene therapy (817)
GLP-1 (1148)
Government (4856)
Grass and pollen (6)
Guidances (422)
Healthcare (19490)
Hematology (194)
HIV (93)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (117)
Immunology and inflammation (337)
Immuno-oncology (116)
Indications (225)
Infectious disease (3195)
Inflammatory bowel disease (235)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (326)
Interviews (321)
IPO (16974)
IRA (53)
Job creations (3721)
Job search strategy (1444)
JPM (67)
Kidney cancer (21)
Labor market (112)
Layoffs (612)
Leadership (44)
Legal (8033)
Liver cancer (105)
Longevity (36)
Lung cancer (860)
Lymphoma (486)
Machine learning (66)
Management (61)
Manufacturing (1189)
Marketing (4)
MASH (219)
Medical affairs (1)
Medical device (14157)
Medtech (14332)
Mergers & acquisitions (20631)
Metabolic disorders (1727)
mRNA (259)
Multiple sclerosis (206)
NASH (20)
Neurodegenerative disease (495)
Neuropsychiatric disorders (121)
Neuroscience (3635)
Neurotech (1)
NextGen: Class of 2026 (6776)
Non-profit (4613)
Now hiring (83)
Obesity (807)
Opinion (323)
Ovarian cancer (246)
Pain (275)
Pancreatic cancer (364)
Parkinson's disease (416)
Partnered (37)
Patents (651)
Patient recruitment (797)
Peanut (68)
People (61422)
Pharmaceutical (70)
Pharmacy benefit managers (34)
Phase 1 (23126)
Phase 2 (32449)
Phase 3 (23958)
Pipeline (10067)
Policy (348)
Postmarket research (2607)
Preclinical (9900)
Press Release (67)
Prostate cancer (346)
Psychedelics (68)
Radiopharmaceuticals (369)
Rare diseases (1268)
Real estate (6085)
Recruiting (72)
Regulatory (26430)
Reports (56)
Research institute (2525)
Resumes & cover letters (356)
Rett syndrome (46)
RNA editing (30)
RSV (90)
Schizophrenia (192)
Series A (337)
Series B (249)
Service/supplier (11)
Sickle cell disease (131)
Special edition (30)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (3844)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (88)
The Weekly (101)
Vaccines (1188)
Venture capital (132)
Weight loss (522)
Women's health (143)
Worklife (22)
Date
Today (80)
Last 7 days (443)
Last 30 days (2161)
Last 365 days (31271)
2026 (16934)
2025 (31055)
2024 (36232)
2023 (41011)
2022 (52276)
2021 (56759)
2020 (54917)
2019 (47413)
2018 (35693)
2017 (33021)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (760)
Alabama (99)
Alaska (7)
Arizona (377)
Arkansas (16)
Asia (41477)
Australia (6906)
California (14315)
Canada (4018)
China (1569)
Colorado (614)
Connecticut (634)
Delaware (439)
Europe (91303)
Florida (2136)
Georgia (454)
Hawaii (3)
Idaho (63)
Illinois (1183)
India (101)
Indiana (639)
Iowa (27)
Japan (610)
Kansas (137)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1696)
Massachusetts (10389)
Michigan (381)
Minnesota (776)
Mississippi (6)
Missouri (151)
Montana (35)
Nebraska (30)
Nevada (150)
New Hampshire (89)
New Jersey (3754)
New Mexico (33)
New York (3742)
North Carolina (1861)
North Dakota (10)
Northern California (7220)
Ohio (428)
Oklahoma (23)
Oregon (44)
Pennsylvania (2823)
Puerto Rico (31)
Rhode Island (54)
South America (1127)
South Carolina (88)
South Dakota (2)
Southern California (5661)
Tennessee (233)
Texas (2290)
United States (50635)
Utah (425)
Vermont (2)
Virginia (352)
Washington D.C. (82)
Washington State (1163)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
751,615 Results for "vistagen therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuropsychiatric disorders
Vistagen in freefall as social anxiety drug fails Phase 3
Despite the late-stage fail, Vistagen will nevertheless continue to push its drug candidate forward and meet with the FDA to align on a potential registrational path.
July 1, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
June 16, 2026
·
12 min read
Press Releases
Vistagen to Participate in Jefferies 2026 Global Healthcare Conference
May 27, 2026
·
1 min read
Press Releases
Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer
May 19, 2026
·
5 min read
Press Releases
Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
June 30, 2026
·
11 min read
Press Releases
Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder
June 9, 2026
·
9 min read
Press Releases
Vistagen to Participate in Upcoming March 2026 Investor Conferences
March 3, 2026
·
1 min read
Press Releases
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
February 26, 2026
·
1 min read
Press Releases
Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
May 8, 2026
·
10 min read
1 of 75,162
Next
